synthetic biologics inc (SYN:NYSE Amex)
C. Evan Ballantyne
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 6 different industries.|
As of Fiscal Year 2014
Mr. C. Evan Ballantyne has been Chief Financial Officer of Agenus Inc. since June 2015. Mr. Ballantyne is responsible for all aspects of financial, accounting, investor relations and corporate communication functions. He served as the Chief Financial Officer and Executive Vice President at Trovis Pharmaceuticals LLC from August 2006 to April 2011. Mr. Ballantyne has more than 30 years of financial and operations experience. Mr. Ballantyne served as Principal Accounting ...
155 Gibbs StreetPhone: 734-332-7800
Rockville, Maryland 20850
Board Members Memberships*There is no Board Members Memberships data available.
The University Of Western Ontario
University Of Windsor
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|There is no Competitor Compensation data available.|